Treatment of portal hypertension and cirrhosis
AssigneeNoorik Biopharmaceuticals AG
InventorIker Navarro
Life of this patent
Estimating the term…
Abstract
Methods and formulations are provided for the treatment and prevention of portal hypertension.
Claims2
A method for treating a subject suffering from portal hypertension comprising administering ambrisentan wherein an effective amount of ambrisentan is administered to the subject, wherein ambrisentan is administered to a treated subject such that the plasma levels of ambrisentan are maintained below 10 ng/ml.
A method for treating a subject suffering from portal hypertension associated with cirrhosis comprising administering ambrisentan wherein an effective amount of ambrisentan is administered to the subject, wherein ambrisentan is administered to a treated subject such that the plasma levels of ambrisentan are maintained below 10 ng/ml.
Dependencies are inferred from the claim text.